Pharmaceutical cold chain management services ensure that temperaturesensitive medicines and vaccines reach you safely. Without proper management, biologics and vaccines can lose potency—the World Health Organization estimates that up to half of vaccines are wasted globally due to inadequate temperature control. As terapias celulares e genéticas são ainda mais exigentes; they often require ultralow temperatures below –80 °C to remain viable. As personalised medicines, biologics and mRNA vaccines become mainstream, the need for reliable cold chain services grows. This article demystifies the components, regulamentos, technologies and trends shaping pharmaceutical cold chain management in 2025 and offers practical guidance tailored to your needs.

Why robust cold chain management services are essential – includes vaccine waste statistics and risks for cell and gene therapies
Key components of pharmaceutical cold chains – covers packaging, transporte, monitoring and skilled personnel
How regulations and standards affect your operations – summarises GDP, cGMP, TCR and WHO guidelines and offers compliance tips
Technologies reshaping cold chain logistics in 2025 – explores automation, IoT, blockchain, AI and sustainable practices
Market insights and emerging trends – provides fresh data on market size, growth drivers and regional variations
Dicas práticas e perguntas frequentes – offers actionable advice and answers to common questions
Why Are Pharmaceutical Cold Chain Management Services Critical?
Cold chains protect patient safety and business value. Temperature excursions can degrade biologics, vacinas e terapias celulares, leading to financial waste and compromised efficacy. Recent research shows that up to 20 % of temperaturesensitive healthcare products are damaged during distribution. With the cell and gene therapy market projected to exceed USD 81 bilhão por 2029, any failure can jeopardise lifesaving treatments. Boas Práticas de Distribuição (PIB) and related regulations mandate validated systems to maintain temperature integrity and traceability. O não cumprimento pode resultar em recalls de produtos, regulatory penalties and loss of trust.
Temperature Sensitivity of Modern Medicines
Different therapies have distinct temperature requirements. Understanding these ranges helps you select the right packaging, transport and monitoring solutions. The table below summarises key categories:
| Faixa de temperatura | Examples of Products | Practical Meaning for You |
| Controlled ambient (15 - 25 °C) | Tablets, some antibiotics | Use insulated packaging to prevent spikes; logistics are simpler but still require traceability. |
| Refrigerado (2 - 8 °C) | Vacinas, insulina, Medicamentos GLP 1 | Stay within a narrow band; delays or poor packaging can render products ineffective. |
| Congelado (–20 °C a 0 °C) | Certain biologics, produtos sanguíneos | Requires robust insulation and phasechange materials; monitoring is crucial to avoid thawing. |
| Deep frozen / criogênico (< –80 °C) | Terapias celulares e genéticas, Vacinas de mRNA | Needs specialised freezers and dry ice or liquid nitrogen; even short excursions can destroy potency. |
Implicações práticas: If your product falls into the refrigerated or frozen categories, ensure your logistics provider uses validated packaging with phasechange materials (PCMs) and realtime monitoring. For cryogenic therapies, portable ultralow freezers and dryice replenishment should be standard. Always assess each product’s stability profile and define acceptable temperature ranges and excursion durations.
Regulatory Frameworks: PIB, cGMP, TCR and WHO Guidelines
Regulators enforce strict rules to safeguard product quality. Boas Práticas de Distribuição (PIB) and IATA Temperature Control Regulations (TCR) require Time and Temperature Sensitive labels on air cargo and mandate acceptance checklists. The FDA’s current Good Manufacturing Practice (cGMP) regulations stipulate that drugs must be stored under appropriate conditions of temperature, humidity and light. A Organização Mundial da Saúde (QUEM) Good Distribution Practices provide guidance on maintaining acceptable temperatures, pest control and calibrated monitoring equipment. The following table summarises key frameworks:
| Framework | Geographic scope | Propósito | O que isso significa para você |
| EU GDP guidelines | Europa | Define standards for wholesale distribution of medicines; ensure correct storage, stock turnover and traceability | Store products within specified temperatures, document stock movements and perform quality audits. |
| AQUI ESTÁ TCR | International air freight | Require Time and Temperature Sensitive labels on cargo and training for ground handlers | Label cargo with temperature range, complete checklists and train staff to handle temperaturesensitive consignments. |
| FDA cGMP (21 Parte cfr 211) | Estados Unidos | Mandate proper storage conditions, stability testing and equipment calibration | Monitorar temperatura, humidity and light; perform stability testing and keep calibration records. |
| WHO GDP | Global | Provide guidance on maintaining acceptable temperatures and mapping storage areas | Calibrate thermometers, conduct temperature mapping and store monitoring data for at least shelflife plus one year. |
| USP <1079> Good Storage and Shipping | Estados Unidos | Recommend medicalgrade refrigeration, stability testing and digital data loggers | Use medicalgrade fridges with fanforced air circulation and monitor temperature daily with digital data loggers. |
Dicas para conformidade:
Create a regulatory matrix that lists each product’s destination markets and corresponding regulations; this prevents oversight when exporting to multiple regions.
Standardise SOPs: develop procedures that satisfy the strictest requirements across regulations to reduce complexity.
Centralise documentation: maintain a unified quality management system where calibration certificates, temperature logs and training records are stored.
Engage certified thirdparty logistics providers: ensure your partners understand GDP, TCR and cGMP requirements and have appropriate equipment.
Mantenha-se informado: subscribe to updates from agencies like EMA, FDA and IATA to remain compliant.
Key Components of Pharmaceutical Cold Chain Management Services
Maintaining drug potency demands a holistic approach built on four pillars: embalagem, transporte, monitoramento contínuo e skilled personnel. Each component works together to prevent temperature excursions, contamination and delays.
Soluções de embalagem: From PhaseChange Materials to EcoFriendly Innovations
Packaging is your first line of defence. Modern solutions use insulation, phasechange materials and smart cooling systems to maintain required temperatures. The following table summarises common options and their benefits:
| Solução de embalagem | Descrição | Benefício prático |
| Materiais de mudança de fase (PCMs) | Materials that absorb or release latent heat at target temperatures | Stabilise temperature during transit; reduce dependence on external power. |
| Painéis isolados a vácuo (VIPs) | Highperformance insulation panels with minimal thermal conductivity | Extend shipment duration without dry ice; ideal para longas distâncias. |
| Cryogenic Freezers | Portable units capable of maintaining –80 °C to –150 °C storage | Support cell and gene therapy shipments and remote clinical trials. |
| Reusable gel or waterbased ice packs | Maintain 2–8 °C or below; waterbased packs emit 39 % less CO₂ during production | Reduce carbon emissions and offer cost savings (5.7 tonnes of CO₂ saved per million packs). |
| Ecofriendly insulation materials | Paperbased liners, fibre composites and recyclable plastics | Reduce singleuse plastic waste and align with circular economy goals. |
Dicas práticas: Use validated packaging that matches your product’s temperature range. For longhaul shipments, consider VIPs combined with PCMs to reduce dry ice consumption. When sustainability matters, choose ecofriendly materials and waterbased ice packs to lower your carbon footprint.
Transportation and Handling: Keeping Products Safe on the Move
Transportation is more than moving goods; it’s about maintaining conditions from door to door. Passive cooling solutions (recipientes isolados) are complemented by active systems—refrigerated trucks, airfreight containers and temperaturecontrolled warehouses. Em 2024, transportation services accounted for 46.3 % of the healthcare cold chain logistics market and air freight held 41 % Quota de mercado. Siga estas práticas recomendadas:
Planejamento de rota: use predictive analytics and AI to avoid traffic, customs delays and extreme weather.
GPSenabled shippers: realtime location and temperature data allow immediate intervention during deviations.
Contingency stock: keep backup coolant, dry ice or portable freezers for unexpected delays.
Monitor handoffs: ensure clear responsibility at transfer points between carriers, warehouses and clinics.
Continuous Monitoring and Skilled Personnel
Monitoring is the nervous system of the cold chain. Sensores de IoT, data loggers and wireless communication provide endtoend visibility. These devices collect temperature, humidity and location data every few minutes, sending alerts via SMS or app when thresholds are breached. Blockchain creates a tamperproof ledger of temperature and chainofcustody data, improving transparency and compliance. IA e análise preditiva optimise routes and anticipate equipment failures by analysing realtime and historical data.
Skilled personnel remain essential. Train drivers, warehouse staff and quality teams on GDP requirements, loading practices, monitoring equipment and corrective actions. Regular drills and refresher courses help prevent human error—the leading cause of cold chain failures. Establish SOPs for responding to temperature excursions, including quarantine, documentation and rootcause analysis.
Technologies Shaping Cold Chain Management in 2025
Pharmaceutical cold chains are being transformed by technologies that improve compliance, eficiência e sustentabilidade. The table below summarises the main innovations and their benefits:
| Tecnologia | Exemplo de uso | Benefícios | Significado para você |
| Armazenamento automatizado & retrieval systems (AS/RS) | Robots and cranes move pallets in cold warehouses | Reduce labour costs and errors; correr 24/7 | Faster order fulfilment and consistent temperature control |
| Sensores de IoT & rastreamento em tempo real | Connected devices monitor temperature, umidade e localização | Detect issues quickly; provide data for audits; improve customer trust | Less spoilage and easier compliance |
| Inteligência artificial & análise preditiva | Algorithms forecast demand, predict equipment failures and optimise delivery routes | Prevent breakdowns; cut fuel use; anticipate demand spikes | Reduced delays, lower costs and improved service reliability |
| Blockchain | Tamperproof digital ledger recording each shipment event | Endtoend traceability; faster customs clearance; fraud reduction | Builds trust with regulators and customers |
| Robótica & drones | Autonomous vehicles and drones handle packages and lastmile delivery | Expand lastmile reach; operate efficiently in remote areas | Faster deliveries and reduced labour shortages |
Automação e Robótica
Only about 20 % of warehouses are automated, leaving ample room for efficiency gains. Sistemas automatizados de armazenamento e recuperação (AS/RS) and robotic handlers operate continuously, improving throughput and reducing human error. When implementing robotics, start with highvolume areas where pickandplace activities are repetitive. Automation not only lowers costs but also maintains consistent temperature zones, preventing “hot spots” in highdensity warehouses.
IoTEnabled Monitoring
IoT devices—sensors, smart tapes and data loggers—collect temperature, humidity and location data every few minutes. Integration with GPS ensures precise tracking and enables proactive intervention. Combining IoT data with predictive analytics identifies patterns that may lead to excursions, such as equipment malfunction or customs delays. Choose devices with long battery life and regulatory compliance, and integrate their data into cloud dashboards for realtime analysis.
Blockchain for EndtoEnd Traceability
Blockchain records transactions in an immutable ledger. Na cadeia de frio, it creates a shared, tamperproof history of temperature readings and chainofcustody events. This technology is especially useful for vaccines and highvalue biologics where data integrity is paramount. Implement blockchain when multiple partners (fabricantes, transportadoras, Clínicas) need shared visibility and trust. Integrate blockchain data with existing quality systems to simplify audits and accelerate customs clearance.
Inteligência Artificial e Análise Preditiva
AI algorithms optimise routes, anticipate equipment failures and forecast demand. AIpowered route optimisation leverages traffic and weather analysis to shorten transit times. Predictive analytics identify patterns that may lead to temperature excursions before they occur, allowing corrective actions such as rerouting shipments or replacing faulty equipment. Use AI not only for routing but also for inventory management and demand forecasting to reduce waste and stockouts.
Sustainable Practices and Packaging
Cold chain logistics consume significant energy and contribute about 2 % das emissões globais de CO₂. Regulators and consumers expect greener operations. Sustainable packaging solutions—such as recyclable insulated containers, biodegradable wraps and reusable cold packs—reduce waste and carbon footprint. Waterbased ice packs emit 39 % less CO₂ compared with gel packs and save 5.7 tonnes of CO₂ per million packs. Energyefficient refrigeration upgrades and solarpowered cold storage units lower operating costs; solar rates range from 3.2–15.5 ¢/kWh, below the average utility rate of 13.10 ¢/kWh. Incorporate hybrid energy sources and renewable refrigerants to meet environmental goals and reduce expenses.
Smart Packaging and RealTime Data
Smart packaging integrates sensors and communication modules directly into containers, transmitting realtime temperature data to logistics teams. This approach reduces risk of lost shipments and supports analytics by aggregating data across shipments. Start with pilot projects for highvalue products and ensure your IT infrastructure can handle the data volume.
Current Trends and Market Insights for 2025
The pharmaceutical cold chain market is expanding rapidly. The coldchain pharma market grew from USD 8.85 bilhão em 2024 para USD 10.04 bilhão em 2025 e espera-se que alcance USD 18.2 bilhão por 2030 com um 12.75 % Cagr. Healthcare cold chain logistics overall reached USD 62.5 bilhão em 2025 and is projected to hit USD 95.1 bilhão por 2030, representando um 9.5 % Cagr. Transportation services account for 46.3 % of the market and air freight holds 41 % compartilhar.
Market Growth Drivers
Vários fatores impulsionam esse crescimento:
Rise of biologics, cell and gene therapies: advanced therapeutics require cryogenic logistics and precise temperature control. These therapies are expanding at an 18.9 % Cagr.
Global vaccination campaigns and pandemic stockpiles: mass immunisation efforts continue to demand robust cold chain distribution.
Stricter regulatory enforcement: regulators are tightening GDP and Good Manufacturing Practice requirements, increasing inspection frequency and traceability expectations.
Infrastructure investments: expansion of temperaturecontrolled warehouses and logistics networks improves coverage and reliability.
Decentralised clinical trials and directtopatient deliveries: moving trials outside traditional sites boosts lastmile cold chain demand.
Tendências emergentes
The following trends will shape cold chain management through 2025:
Ultracold and cryogenic logistics: portable freezers capable of maintaining –80 °C to –150 °C are becoming standard for gene therapies.
Endtoend visibility and realtime data: integration of IoT, blockchain and AI delivers complete traceability and rapid response to deviations.
Automação e robótica: labour shortages accelerate adoption of robotic systems, improving efficiency and reducing errors.
Sustentabilidade e economia circular: embalagem ecológica, solarpowered storage and reduced emissions are priorities. Waterbased refrigerants and recyclable liners align with regulations and consumer expectations.
Decentralised manufacturing and localised supply chains: to mitigate global disruptions, pharmaceutical companies invest in local production facilities and microfulfilment centres.
Market Insights and Regional Variations
Regionspecific data reveal where opportunities and challenges lie:
| Region/Sector | 2025 Valor | Motores de crescimento | Implicações |
| Logística global da cadeia de frio | USD 436.3 bilhão | Rising demand for perishable foods and biologics; ecommerce and directtoconsumer models | Companies must expand capacity and adopt technology to handle volume. |
| Ásia-Pacífico | Highest CAGR (~14,3 %) | Population growth, urbanisation and new health regulations | Opportunity for investment in modern warehouses and refrigerated fleets. |
| América do Norte (food cold chain) | USD 86.67 bilhão por 2025 | Growth in meal kits, plantbased products and organic foods | Demand for lastmile cold storage and sustainable packaging. |
| Cadeia de frio farmacêutica | Cagr 4.71 % (20242029) and projected volume USD 1,454 bilhão por 2029 | Terapias genéticas e celulares, vacinas e produtos biológicos | Need for ultracold storage, cryogenic freezers and traceability. |
| Embalagem da cadeia de frio | USD 30.88 bilhão em 2025 crescendo para USD 64.49 bilhão por 2032 | Demand for temperaturecontrolled shipping and ecofriendly packaging | Opportunities for reusable pallet shippers, VIPs and biodegradable wraps. |
Navigating Regulations and Compliance in the Pharmaceutical Cold Chain
Why regulations matter: GDP and TCR guidelines protect patients and preserve drug potency by ensuring medicines are stored and transported under correct conditions. Regulations unify quality standards across borders, preventing counterfeit products and facilitating global supply chains. A Lei de Segurança da Cadeia de Abastecimento de Medicamentos (DSCSA) and the EU’s Falsified Medicines Directive demand serialization and tracking to prevent counterfeit medicines. The FDA’s 21 Cfr 211.142 mandates that drug products be stored under appropriate conditions of temperature, humidity and light. Junto, these rules require robust processes, continuous monitoring and corrective actions.
Understanding GDP, TCR and cGMP Requirements
| Exigência | Fonte | Detalhes | Por que isso importa para você |
| Storage conditions | EU GDP; FDA 21 Cfr 211.142 | Maintain appropriate temperature, humidity and light to preserve product quality | You must record storage conditions and adjust equipment to stay within specified ranges. |
| Temperature mapping and calibration | Diretrizes da OMS | Calibrate monitoring devices and map storage areas to identify hot or cold spots | Mapping ensures sensors are placed where fluctuations are likely, preventing unnoticed excursions. |
| Labelling and documentation | AQUI ESTÁ TCR | Use Time and Temperature Sensitive labels on air cargo and complete acceptance checklists | Proper labelling ensures handlers understand the required temperature range; checklists verify compliance before loading. |
| Traceability and serialization | DSCSA; EU Falsified Medicines Directive | Implement serialization and tracking systems to identify individual packages | Traceability prevents counterfeit products and enables rapid recalls in case of quality issues. |
| Equipment qualification and monitoring | USP <1079>; CDC Toolkit | Use medicalgrade equipment, perform stability and recovery testing and monitor temperature continuously with digital data loggers | Qualified equipment maintains uniform temperatures; continuous monitoring detects excursions early and preserves product potency. |
Implementing Best Practices: Practical Tips for Your Cold Chain Program
Investing in proper infrastructure and procedures reduces risk and supports compliance. Here are actionable tips based on industry evidence:
Assess product stability: work with quality teams to define acceptable temperature ranges, excursion durations and contingency plans.
Invista em treinamento: human error is a leading cause of excursions; regularly train staff on loading practices, monitoring equipment and corrective actions.
Use validated packaging: adopt phasechange materials and vacuuminsulated panels to maintain stable temperatures during delays.
Create emergency SOPs: develop standard operating procedures for responding to deviations, including quarantine, documentation and rootcause analysis.
Perform temperature mapping: calibrate sensors and map storage areas to identify hot spots and ensure sensors are placed where fluctuations occur.
Implement digital monitoring: equip shipments with IoT sensors and integrate data into dashboards for realtime analysis.
Plano para a sustentabilidade: switch to ecofriendly packaging, waterbased refrigerants and solarpowered cold storage to reduce carbon footprint and energy costs.
Form strategic partnerships: collaborate with local technology providers, packaging firms and thirdparty logistics partners to expand capacity and share expertise.
Caso real: During the Pfizer–BioNTech COVID19 vaccine rollout, ultralow temperature requirements (–70 °C) posed significant logistics challenges. The company used GPSenabled thermal shippers, routine dryice replenishment and continuous digital monitoring to ensure safe delivery. This example highlights the importance of proactive monitoring and validated packaging for new therapies.
2025 Últimos Desenvolvimentos e Tendências
Cold chain logistics are evolving quickly, with innovations and market dynamics reshaping operations across sectors. This section highlights notable developments.
Automação, IoT and AI: The Engine of 2025 Cold Chain Updates
The convergence of automation, IoT and AI drives productivity and transparency. As noted earlier, sistemas automatizados de armazenamento e recuperação, IoT sensors and predictive analytics work together to maintain temperature and optimise routes. IoT devices provide realtime visibility into temperature, umidade e localização, allowing you to detect issues before spoilage occurs. AI analyses this data to optimise routes, forecast demand and perform predictive maintenance. Combinado, these technologies reduce waste, improve compliance and deliver faster, more reliable service.
Market Dynamics and Diversification
The cold chain logistics market is expanding from a niche service to critical infrastructure. The global market is valued at USD 436.3 bilhão em 2025 with a forecast CAGR of 13.46 % através 2034. Ásia-Pacífico leads growth (em volta 14.3 % Cagr) due to population expansion and new health regulations, enquanto América do Norte drives demand for lastmile cold storage and sustainable packaging, avaliado em USD 86.67 bilhão. Pharmaceutical cold chain services, fuelled by gene and cell therapies, require ultracold storage and advanced tracking. The cold chain packaging market will grow from USD 30.88 bilhão em 2025 para USD 64.49 bilhão por 2032, reflecting increased demand for vacuuminsulated panels, reusable pallet shippers and biodegradable wraps.
Sustentabilidade e Regulamentação
A sustentabilidade não é mais opcional. Cold chain logistics produces roughly 2 % das emissões globais de CO₂. Solarpowered cold storage units reduce operating costs—commercial solar rates range from 3.2–15.5 ¢/kWh comparado com 13.10 ¢/kWh average utility rates. Moving frozen storage from –18 °C to –15 °C reduces energy consumption without compromising safety. Embalagem sustentável, such as recyclable containers and biodegradable wraps, lowers environmental impact and meets emerging regulations. Policies like the Gulf region’s Net Zero 2050 strategy and the adoption of BRC and SQF standards drive investment in energyefficient infrastructure and advanced traceability.
Blockchain, Solar and Cryogenic Innovations
As inovações incluem blockchainenabled traceability, armazenamento refrigerado movido a energia solar, Sensores de IoT, Otimização de rotas com tecnologia de IA e congeladores criogênicos portáteis. Blockchain pilots have cut customs clearance times by recording shipment events in an immutable ledger. Solarpowered cold storage reduces costs and ensures product integrity in remote regions. IoTenabled sensors send realtime alerts for temperature deviations, while AI uses traffic and weather data to plan routes and reduce fuel consumption. Portable cryogenic freezers maintain –80 °C to –150 °C with realtime tracking, supporting transport of biologics and gene therapies.
Regional Trends and Strategic Partnerships
Different regions face unique challenges and opportunities. In the Middle East, extreme heat and complex crossborder trade drive investment in IoT, AI and blockchain to provide realtime visibility and predictive intelligence. Solarpowered storage and compostable packaging align with regional sustainability goals. AsiaPacific focuses on expanding cold storage capacity and adopting advanced packaging technologies. North America emphasises lastmile delivery and directtoconsumer models, investing in robotics, drones and data analytics. Europe’s strict regulations push adoption of advanced temperature control and sustainable materials.
Strategic partnerships between food producers, packaging suppliers and technology providers improve resilience and product development. Por 2025, aproximadamente 74 % of logistics data will be standardised, permitindo uma integração perfeita entre cadeias de abastecimento.
Perguntas frequentes
Q1: Why is cold chain important for vaccines and biologics?
Vaccines and biologics are sensitive to temperature changes; even small excursions can render them ineffective. Up to half of vaccines may be wasted globally each year due to inadequate temperature control. A validated cold chain preserves efficacy and protects patient safety.
Q2: How do IoT sensors enhance cold chain monitoring?
IoT sensors collect temperature and location data in real time, sending alerts when conditions deviate from set ranges. They enable proactive intervention, reduce waste and provide auditable records for regulators.
Q3: O que são materiais de mudança de fase?
Materiais de mudança de fase (PCMs) absorb or release heat at a specific temperature, stabilising the internal environment of a package. They help maintain temperature without continuous power and reduce dryice consumption.
Q4: How does blockchain benefit the pharmaceutical cold chain?
Blockchain creates a tamperproof ledger of temperature data, chainofcustody events and regulatory documentation. Melhora a transparência, security and compliance, especially when multiple stakeholders are involved.
Q5: Can sustainable packaging meet strict temperature requirements?
Sim. Innovations such as waterbased refrigerants, biodegradable liners and vacuuminsulated panels offer high thermal performance while reducing carbon emissions. Companies adopting these materials align with regulations and consumer demand for ecofriendly solutions.
Resumo & Recomendações
Takeaways -chave:
Prioritise product integrity and compliance: até 50 % of vaccines are wasted due to poor temperature control. Invest in validated packaging, realtime monitoring and staff training to reduce risk.
Entenda os regulamentos: adhere to GDP, cGMP and TCR requirements and maintain proper documentation. Create a regulatory matrix to navigate overlapping standards.
Aproveite a tecnologia: automação, Sensores de IoT, blockchain and AI optimise routes, ensure traceability and reduce operational costs. Start with small pilots, então dimensione.
Abrace a sustentabilidade: embalagem ecológica, waterbased refrigerants and solarpowered storage cut emissions and energy costs.
Monitore as tendências do mercado: anticipate growth in cell and gene therapies, decentralised clinical trials and regional market expansions. Align your strategy with emerging trends.
Plano de ação:
Assess your current cold chain program: perform a gap analysis against regulatory requirements and industry best practices.
Implementar monitoramento contínuo: adopt IoT sensors and integrate data into a central dashboard for realtime visibility.
Pilotar novas tecnologias: test automation, blockchain or smart packaging on a small scale to evaluate benefits before full deployment.
Train and empower staff: ensure personnel are equipped to use new tools and follow GDPcompliant procedures.
Envolver especialistas: consult specialised cold chain providers like Tempk to design customised solutions and stay ahead of industry trends.
Sobre Tempk
Tempk is a trusted partner in cold chain logistics, providing innovative packaging, temperaturecontrolled transport solutions and comprehensive monitoring technologies. Our research and development centre focuses on sustainable materials and cuttingedge sensors. We offer validated insulated boxes, pacotes de gelo reutilizáveis, vacuuminsulated panels and portable cryogenic freezers. We’ve helped clients reduce carbon emissions by 39 % with waterbased ice packs and save 5.7 tonnes of CO₂ per million packs. With certified facilities and experienced personnel, Tempk ensures regulatory compliance, product integrity and ontime delivery across the globe.
Get started today: Contact us to discuss your unique cold chain requirements. Our experts will design a tailored solution to protect your products, meet regulations and achieve sustainability goals.